These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 349258)
21. Comparative study on the responses of plasma GH to synthetic GH-releasing factor and other stimulatory and inhibitory agents in patients with acromegaly. Hanew K; Sato S; Sasaki A; Shimizu Y; Murakami O; Yoshinaga K Tohoku J Exp Med; 1985 Feb; 145(2):161-6. PubMed ID: 2859672 [TBL] [Abstract][Full Text] [Related]
22. Plasma growth hormone responses to sulpiride in patients with acromegaly. Hanew K; Sato S; Sasaki A; Kasai M; Shimizu Y; Murakami O; Yoshinaga K Tohoku J Exp Med; 1984 Apr; 142(4):445-52. PubMed ID: 6429896 [TBL] [Abstract][Full Text] [Related]
23. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly. Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226 [TBL] [Abstract][Full Text] [Related]
24. Clinical use of pre- and postsurgical evaluation of abnormal GH responses in acromegaly. Arosio M; Giovanelli MA; Riva E; Nava C; Ambrosi B; Faglia G J Neurosurg; 1983 Sep; 59(3):402-8. PubMed ID: 6411870 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the results of trans-sphenoidal surgery in acromegaly by assessment of the growth hormone response to thyrotrophin-releasing hormone. Faglia G; Paracchi A; Ferrari C; Beck-Peccoz P Clin Endocrinol (Oxf); 1978 May; 8(5):373-80. PubMed ID: 417883 [TBL] [Abstract][Full Text] [Related]
26. Luteinizing hormone-releasing hormone and serum growth hormone in insulin-dependent diabetes. Joffe BI; Distiller LA; Sagel J; Lawson M; Morley JE; Seftel HC S Afr Med J; 1977 Jun; 51(26):979-80. PubMed ID: 329438 [TBL] [Abstract][Full Text] [Related]
27. Discordant effects of insulin-hypoglycemia on growth hormone (GH)-releasing hormone-stimulated GH and thyrotropin (TSH)-releasing hormone-stimulated TSH secretion. Kelijman M; Frohman LA J Clin Endocrinol Metab; 1988 Apr; 66(4):872-5. PubMed ID: 3126217 [TBL] [Abstract][Full Text] [Related]
28. [Growth hormone secretion in acromegaly after isolated and combined use of the insulin hypoglycemia, LH-RH and TRH test]. Schneider KR; Wiegelmann W; Solbach HG; Krüskemper HL Verh Dtsch Ges Inn Med; 1978; (84):1438-41. PubMed ID: 105492 [No Abstract] [Full Text] [Related]
29. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy. Hoyte KM; Martin JB J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457 [TBL] [Abstract][Full Text] [Related]
30. [Stimulation of growth hormone and prolactin secretion with TRH in acromegaly (author's transl)]. von Werder K; Fahlbusch R; Gay R; Pickhardt CR; Schultz B Klin Wochenschr; 1976 Apr; 54(7):335-8. PubMed ID: 177804 [TBL] [Abstract][Full Text] [Related]
31. Enhanced GH responses to combined administration of GHRP and GHRH in patients with acromegaly. Hanew K; Utsumi A; Sugawara A; Shimizu Y; Abe K J Clin Endocrinol Metab; 1994 Mar; 78(3):509-12. PubMed ID: 8126120 [TBL] [Abstract][Full Text] [Related]
32. Differences in autonomity of growth hormone secretion in patients with acromegaly. Hanew K; Aida M; Tano T; Ojima M; Nishizato K Tohoku J Exp Med; 1976 Oct; 120(2):159-67. PubMed ID: 824758 [TBL] [Abstract][Full Text] [Related]
33. Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment. Boizel R; Halimi S; Labat F; Cohen R; Bachelot I J Clin Endocrinol Metab; 1987 Feb; 64(2):304-8. PubMed ID: 3098773 [TBL] [Abstract][Full Text] [Related]
34. Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion. Arosio M; Ambrosi B; Guglielmino L; Faglia G J Endocrinol Invest; 1985 Oct; 8(5):449-53. PubMed ID: 2867112 [TBL] [Abstract][Full Text] [Related]
35. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540 [TBL] [Abstract][Full Text] [Related]
36. Paradoxical response of growth hormone to peptide histidine methionine in acromegaly: comparison with the effects of thyrotropin-releasing hormone and vasoactive intestinal peptide. Watanobe H; Sasaki S; Sone K; Takebe K J Clin Endocrinol Metab; 1991 May; 72(5):982-5. PubMed ID: 1902488 [TBL] [Abstract][Full Text] [Related]
37. Assessment of GH releasing hormone activity in sephadex-separated fractions of porcine hypothalamic extracts by hypophyseal portal vessel infusion in the rat. Takahara J; Arimura A; Schally AV Acta Endocrinol (Copenh); 1975 Mar; 78(3):428-34. PubMed ID: 235186 [TBL] [Abstract][Full Text] [Related]
38. [Growth hormone, gonadotropins and cortisol in the plasma of males under combined application of the insulin-hypoglycaemia-LH-RH test (author's transl)]. Wiegelmann W; Kley HK; Solbach HG; Krüskemper HL Klin Wochenschr; 1974 Feb; 52(4):194-6. PubMed ID: 4600183 [No Abstract] [Full Text] [Related]